» Articles » PMID: 28515724

An Analysis of Trafficking Receptors Shows That CD44 and P-Selectin Glycoprotein Ligand-1 Collectively Control the Migration of Activated Human T-Cells

Overview
Journal Front Immunol
Date 2017 May 19
PMID 28515724
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Selectins guide the traffic of activated T-cells through the blood stream by mediating their tethering and rolling onto inflamed endothelium, in this way acting as beacons to help navigate them to sites of inflammation. Here, we present a comprehensive analysis of E-selectin ligands expressed on activated human T-cells. We identified several novel glycoproteins that function as E-selectin ligands. Specifically, we compared the role of P-selectin glycoprotein ligand-1 (PSGL-1) and CD43, known E-selectin ligands, to CD44, a ligand that has not previously been characterized as an E-selectin ligand on activated human T-cells. We showed that CD44 acts as a functional E-selectin ligand when expressed on both CD4 and CD8 T-cells. Moreover, the CD44 protein carries a binding epitope identifying it as hematopoietic cell E- and/or L-selectin ligand (HCELL). Furthermore, by knocking down these ligands individually or together in primary activated human T-cells, we demonstrated that CD44/HCELL, and not CD43, cooperates with PSGL-1 as a major E-selectin ligand. Additionally, we demonstrated the relevance of our findings to chronic autoimmune disease, by showing that CD44/HCELL and PSGL-1, but not CD43, from T-cells isolated from psoriasis patients, bind E-selectin.

Citing Articles

Preclinical Efficacy of VTX-0811: A Humanized First-in-Class PSGL-1 mAb Targeting TAMs to Suppress Tumor Growth.

Novobrantseva T, Manfra D, Ritter J, Razlog M, ONuallain B, Zafari M Cancers (Basel). 2024; 16(16).

PMID: 39199551 PMC: 11352552. DOI: 10.3390/cancers16162778.


Immune Cell Migration to Cancer.

Ryan A, Kim M, Lim K Cells. 2024; 13(10.

PMID: 38786066 PMC: 11120175. DOI: 10.3390/cells13100844.


α1,3-fucosylation treatment improves cord blood CD34 negative hematopoietic stem cell navigation.

Al-Amoodi A, Kai J, Li Y, Malki J, Alghamdi A, Al-Ghuneim A iScience. 2024; 27(2):108882.

PMID: 38322982 PMC: 10845921. DOI: 10.1016/j.isci.2024.108882.


CD34 HSPCs-derived exosomes contain dynamic cargo and promote their migration through functional binding with the homing receptor E-selectin.

Isaioglou I, Aldehaiman M, Li Y, Lahcen A, Rauf S, Al-Amoodi A Front Cell Dev Biol. 2023; 11:1149912.

PMID: 37181754 PMC: 10166801. DOI: 10.3389/fcell.2023.1149912.


Tumor-targeted superantigens produce curative tumor immunity with induction of memory and demonstrated antigen spreading.

Azulay M, Shahar M, Shany E, Elbaz E, Lifshits S, Torngren M J Transl Med. 2023; 21(1):222.

PMID: 36967382 PMC: 10041807. DOI: 10.1186/s12967-023-04064-z.


References
1.
Jacobs P, Sackstein R . CD44 and HCELL: preventing hematogenous metastasis at step 1. FEBS Lett. 2011; 585(20):3148-58. PMC: 3195965. DOI: 10.1016/j.febslet.2011.07.039. View

2.
Sellers R . Translating Mouse Models. Toxicol Pathol. 2016; 45(1):134-145. DOI: 10.1177/0192623316675767. View

3.
Hutas G, Bajnok E, Gal I, Finnegan A, Glant T, Mikecz K . CD44-specific antibody treatment and CD44 deficiency exert distinct effects on leukocyte recruitment in experimental arthritis. Blood. 2008; 112(13):4999-5006. PMC: 2597605. DOI: 10.1182/blood-2008-04-150383. View

4.
DeGrendele H, Estess P, Picker L, SIEGELMAN M . CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J Exp Med. 1996; 183(3):1119-30. PMC: 2192320. DOI: 10.1084/jem.183.3.1119. View

5.
Winkler I, Barbier V, Nowlan B, Jacobsen R, Forristal C, Patton J . Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance. Nat Med. 2012; 18(11):1651-7. DOI: 10.1038/nm.2969. View